![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, January 01, 2023 10:57:34 AM
Electromagnetic Pain Relief/Blocking: Feasibility Assessment
Carol Mullenax, PhD, PE, PMP
KBR, Inc.
2020 Innovation Charge Account Award
JSC Chief Technology Office
September 24, 2020
National Aeronautics and Space Administration
Lyndon B. Johnson Space Center
Houston, Texas 77058
1.0 ABSTRACT/EXECUTIVE SUMMARY
Context/Background: Astronauts use pharmaceuticals during spaceflight to manage acute and
chronic pain, but use of analgesics will have drawbacks for exploration-class missions because
the shelf life of these medications is limited, resupply will be curtailed, astronauts may develop
tolerance and/or addiction to these medications, and side effects can include impairment of
cognitive abilities. Electromagnetic devices have been developed that treat pain terrestrially by
affecting neuromodulation–dubbed “electroceuticals”, these devices have varied mechanisms of
action that either stimulate or suppress neural activity in the central nervous system or peripheral
nerves.
https://ntrs.nasa.gov/api/citations/20205008893/downloads/2020ICA_Mullenax_report_24Sep20.pdf
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM